Key facts
- Evernow’s last known valuation is $84.0M (Jun 2020).
- It has raised $52.5M; the latest was Later Stage VC in Mar 2025.
- Notable investors include Alumni Ventures, Mana Ventures, Impact Assets, Gaingels, 8VC — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for Evernow
- ·The full record, as it builds
Funding rounds
No funding rounds for Evernow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Evernow
Developer of an online teleconsultation platform designed to guide women during and after menopause. The company's platform has online access to specialized doctors, science-backed pieces of information, and treatments with conversations and information about effective care for changing hormones, enabling women to live longer and healthier lives.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2019
- Employees
- 30
- Website
- evernow.com/
- Ownership
- Privately Held (backing)
Evernow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Evernow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Evernow in its N-PORT filings yet. We sweep new filings monthly.